Get the Stockscreener App
18.08
0.06%
0.010
After Hours:
18.08
Innoviva Inc stock is traded at $18.08, with a volume of 356.17K.
It is up +0.06% in the last 24 hours and down -3.57% over the past month.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$18.07
Open:
$18.18
24h Volume:
356.17K
Relative Volume:
0.60
Market Cap:
$1.13B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
10.96
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
+0.00%
1M Performance:
-3.57%
6M Performance:
-2.53%
1Y Performance:
+15.38%
1-Day Range:
$18.04
$18.26
1-Week Range:
$17.92
$18.26
52-Week Range:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.08 | 1.13B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Innoviva, Inc. (NASDAQ:INVA) Short Interest Down 10.2% in January - MarketBeat
Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World
Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
(INVA) Investment Analysis - Stock Traders Daily
Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World
Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq
Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
(INVA) Investment Report - Stock Traders Daily
Ratio Review: Analyzing Innoviva Inc (INVA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
Healthcare Watch: Innoviva's Strategic Vision Takes Center Stage at Major Oppenheimer Conference - StockTitan
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Pacer Advisors Inc. - MarketBeat
Franklin Resources Inc Reduces Stake in Innoviva Inc - GuruFocus.com
Brokers Set Expectations for Innoviva FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on Innoviva FY2025 Earnings - MarketBeat
Innoviva (NASDAQ:INVA) investors are up 4.7% in the past week, but earnings have declined over the last five years - Simply Wall St
When (INVA) Moves Investors should Listen - Stock Traders Daily
JPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
JPMorgan Chase & Co. Acquires 72,039 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Armata Pharmaceuticals Announces $35 Million Secured Credit Agre - GuruFocus.com
(INVA) Trading Report - Stock Traders Daily
Principal Financial Group Inc. Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - MarketBeat
Barclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Geode Capital Management LLC Has $26.22 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Barclays PLC Acquires 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Trading (INVA) With Integrated Risk Controls - Stock Traders Daily
Stock Gains You Can't Ignore! - Jomfruland.net
Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years - Yahoo Finance
MML Investors Services LLC Buys 2,985 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Fmr LLC Buys 771 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Wellington Management Group LLP Sells 42,739 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by HighTower Advisors LLC - Defense World
Innoviva, Inc.'s (NASDAQ:INVA) Popularity With Investors Is Under Threat From Overpricing - Simply Wall St
Oversold Conditions For Innoviva (INVA) - Nasdaq
Innoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in November - Defense World
Innoviva enters distribution, license agreement with Basilea for Zevtera - Yahoo Finance
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - BioSpace
Innoviva seals deal for new MRSA antibiotic in the US - Investing.com
Innoviva seals deal for new MRSA antibiotic in the US By Investing.com - Investing.com UK
Innoviva Secures Exclusive Rights to Groundbreaking MRSA Antibiotic Zevtera in Major FDA-Approved Drug Deal - StockTitan
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):